Table 2.
Hazard Associated with each Standard Deviation Change in Peak Vo2.
Model 1 Univariate | Model 2 Demographics | Model 3 Clinical Covariates | ||||
---|---|---|---|---|---|---|
HR § (95% CI) | p-Value | HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
Peak Oxygen Consumption Absolute Peak Vo2 (SD ± 414 mL O2/min) | 0.75 (0.60, 0.93) | 0.010 | 0.60 (0.46, 0.78) | 0.000 | 0.62 (0.47, 0.81) | 0.001 |
% Predicted Peak Vo2 (SD ± 14%) | 0.66 (0.53, 0.84) | 0.001 | 0.63 (0.50, 0.81) | 0.000 | 0.68 (0.53, 0.87) | 0.002 |
Peak Vo2, body mass (SD ± 4 mL O2/min/kg body mass) | 0.69 (0.55, 0.87) | 0.002 | 0.66 (0.52, 0.83) | 0.000 | 0.72 (0.56, 0.91) | 0.007 |
Peak Vo2, lean (SD ± 6 mL/min/kg lean mass) | 0.62 (0.49, 0.78) | 0.000 | 0.63 (0.50, 0.79) | 0.000 | 0.68 (0.53, 0.86) | 0.002 |
O2 Pulse (SD ± 3 mL O2/beat) | 0.81 (0.65, 0.99) | 0.043 | 0.66 (0.52, 0.85) | 0.001 | 0.66 (0.51, 0.85) | 0.002 |
Higher Peak Vo2 is associated with a decreased hazard of death or retransplantation. Model 1—unadjusted Cox proportional hazard model. Model 2—adjusted for age, race/ethnicity, sex, and days from transplant to CPET. Model 3—adjusted for Model 2 variables plus pulmonary vascular resistance, type 2 diabetes, ischemic cardiomyopathy, peripheral-vascular disease, chronic obstructive pulmonary disease, and hemoglobin. Hazard ratios (HR) are for a one standard deviation (SD) change in each metric. Acronyms: Vo2, oxygen consumption.